RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNXT RenovoRx Inc

美国独立日休市 07-03 13:00:00 EDT

1.12

-0.01

-0.88%

盘后1.12

+0.000.00%

16:54 EDT

最高1.15	最低1.11	成交量7,360
今开1.11	昨收1.13	日振幅3.45%
总市值2,683万	流通市值2,631万	总股本2,395万
成交额8,315	换手率0.03%	流通股本2,349万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.12,"timestamp":1720026000000,"preClose":1.13,"halted":0,"volume":7360,"hourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"16:54 EDT","volume":23,"amount":26.91,"timestamp":1720040063427},"delay":0,"floatShares":23488855,"shares":23951825,"eps":-0.684897,"marketStatus":"美国独立日休市","marketStatusCode":7,"change":-0.01,"latestTime":"07-03 13:00:00 EDT","open":1.11,"high":1.149,"low":1.11,"amount":8314.61408,"amplitude":0.034513,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.684897,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720166400000},"adr":0,"listingDate":1629950400000,"adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.13,"latestTime":"09:14 EDT","volume":400,"amount":468,"timestamp":1720012487595},"postHourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"16:54 EDT","volume":23,"amount":26.91,"timestamp":1720040063427},"volumeRatio":0.620852818632445},"requestUrl":"/m/hq/s/RNXT/wiki","defaultTab":"wiki","newsList":[{"id":"2446558461","title":"Renovorx, Inc.盘中异动 早盘快速拉升6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446558461","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446558461?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:31","pubTimestamp":1719495064,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时31分，Renovorx, Inc.股票出现波动，股价快速拉升6.19%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272131049f6c15c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272131049f6c15c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2446984944","title":"Renovorx, Inc.盘中异动 早盘急速上涨6.02%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446984944","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446984944?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:38","pubTimestamp":1719322692,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时38分，Renovorx, Inc.股票出现波动，股价急速上涨6.02%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521381296816a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521381296816a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2445072511","title":"Renovorx, Inc.盘中异动 早盘快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072511","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445072511?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:35","pubTimestamp":1719236122,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时35分，Renovorx, Inc.股票出现异动，股价快速拉升5.45%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213522af8eeb8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213522af8eeb8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2443667800","title":"Renovorx, Inc.股价拉升10.48% 市值跌46.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443667800","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443667800?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:30","pubTimestamp":1718371839,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时30分，Renovorx, Inc.股票出现异动，股价大幅拉升10.48%。截至发稿，该股报1.16美元/股，成交量1.4303万股，换手率0.06%，振幅0.00%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213039aef50877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213039aef50877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2442529475","title":"Renovorx, Inc.盘中异动 早盘急速拉升5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442529475","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442529475?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:34","pubTimestamp":1718199268,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时34分，Renovorx, Inc.股票出现波动，股价快速上涨5.70%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122134299f352cc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122134299f352cc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2442394669","title":"Renovorx, Inc.盘中异动 快速拉升6.31%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442394669","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442394669?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:33","pubTimestamp":1718112784,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时33分，Renovorx, Inc.股票出现异动，股价急速拉升6.31%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406112133049f311d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406112133049f311d7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2439803992","title":"Renovorx, Inc.盘中异动 早盘急速上涨9.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439803992","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439803992?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:35","pubTimestamp":1717162503,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时35分，Renovorx, Inc.股票出现异动，股价急速上涨9.39%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312135039f0afa64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312135039f0afa64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2439647199","title":"Renovorx, Inc.盘中异动 股价大涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439647199","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439647199?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:31","pubTimestamp":1717075919,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时31分，Renovorx, Inc.股票出现波动，股价快速上涨5.69%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213159af8b2888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213159af8b2888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2439507311","title":"Renovorx, Inc.盘中异动 下午盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439507311","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439507311?lang=zh_cn&edition=full","pubTime":"2024-05-30 03:11","pubTimestamp":1717009890,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日03时11分，Renovorx, Inc.股票出现异动，股价急速跳水5.50%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530031130af8af27b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530031130af8af27b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2435784163","title":"RenovoRx 公司报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435784163","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435784163?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607117,"startTime":"0","endTime":"0","summary":"   * RenovoRx Inc   报告了截至1月底的季度调整后每股亏损7美分，高于去年同期的每股-36美分。两位分析师对该季度的平均预期是每股亏损 14 美分。华尔街预期为每股-16美分至-13美分。* RenovoRx Inc 报告的本季度每股收益为亏损 7 美分。* RenovoRx Inc 本季度股价上涨了 8.2%，今年迄今为止亏损了 36.7%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 RenovoRx Inc 的 12 个月目标价中位数为 4.00 美元。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2434985290","title":"Renovorx, Inc.盘中异动 快速上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434985290","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434985290?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:59","pubTimestamp":1715349569,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时59分，Renovorx, Inc.股票出现波动，股价快速上涨5.58%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021592987e871ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021592987e871ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2434039856","title":"RenovoRx Inc   预计每股亏损14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434039856","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434039856?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:03","pubTimestamp":1715346190,"startTime":"0","endTime":"0","summary":"   * RenovoRx Inc    预计在5月13日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)    *    * LSEG分析师对RenovoRx公司的平均预期是每股亏损14美分。* 华尔街对 RenovoRx Inc 的 12 个月目标价中位数为 4.00 美元，高于其上次收盘价 1.35 美元。5月10日 - 本摘要于北京时间 5 月 10 日 13:02 机器生成。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2434804564","title":"Renovorx, Inc.盘中异动 快速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434804564","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434804564?lang=zh_cn&edition=full","pubTime":"2024-05-10 01:35","pubTimestamp":1715276145,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日01时35分，Renovorx, Inc.股票出现波动，股价大幅拉升5.11%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051001354587e86d3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051001354587e86d3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2434703425","title":"Renovorx, Inc.盘中异动 临近收盘急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434703425","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434703425?lang=zh_cn&edition=full","pubTime":"2024-05-09 04:00","pubTimestamp":1715198447,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日04时00分，Renovorx, Inc.股票出现波动，股价大幅拉升5.38%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050904004887e86819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050904004887e86819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2433786617","title":"Renovorx, Inc.盘中异动 股价大涨6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786617","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433786617?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:23","pubTimestamp":1715091827,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时23分，Renovorx, Inc.股票出现波动，股价急速拉升6.35%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722234779264cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722234779264cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2433479852","title":"Renovorx, Inc.盘中异动 快速拉升7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433479852?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:32","pubTimestamp":1715002346,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时32分，Renovorx, Inc.股票出现异动，股价快速上涨7.38%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621322787e85d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621322787e85d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2428146349","title":"Renovorx, Inc.盘中异动 早盘股价大涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428146349","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428146349?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:44","pubTimestamp":1713361487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时44分，Renovorx, Inc.股票出现波动，股价快速拉升6.21%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司。该公司专注于开发实体瘤局部治疗的疗法，并为其主要候选产品 RenovoGem 进行胰腺癌3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214448861e6b77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214448861e6b77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2427007284","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427007284","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427007284?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:06","pubTimestamp":1713193594,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时06分，Renovorx, Inc.股票出现波动，股价快速跳水5.74%。截至发稿，该股报1.15美元/股，成交量1.9412万股，换手率0.12%，振幅9.84%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司。该公司专注于开发实体瘤局部治疗的疗法，并为其主要候选产品 RenovoGem 进行胰腺癌3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041523063487e807d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041523063487e807d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2426260164","title":"Renovorx, Inc.盘中异动 大幅拉升8.70%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426260164","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426260164?lang=zh_cn&edition=full","pubTime":"2024-04-12 00:35","pubTimestamp":1712853301,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日00时35分，Renovorx, Inc.股票出现异动，股价急速上涨8.70%。截至发稿，该股报1.30美元/股，成交量2.1909万股，换手率0.13%，振幅9.62%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司。该公司专注于开发实体瘤局部治疗的疗法，并为其主要候选产品 RenovoGem 进行胰腺癌3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412003501861e5062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412003501861e5062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2426110481","title":"Renovorx, Inc.盘中异动 大幅拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426110481","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426110481?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:30","pubTimestamp":1712680252,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日00时30分，Renovorx, Inc.股票出现波动，股价大幅上涨5.12%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Acrivon Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Nutriband Inc C/Wts 涨幅较大，Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.、Biophytis较为活跃，换手率分别为474.70%、113.95%、111.45%，振幅较大的相关个股有Nutriband Inc C/Wts 、Mymd Pharmaceuticals, Inc.、Biophytis，振幅分别为53.13%、50.11%、40.61%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司。该公司专注于开发实体瘤局部治疗的疗法，并为其主要候选产品 RenovoGem 进行胰腺癌3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410003052861e4467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410003052861e4467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com","stockEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":-0.0261},{"period":"3month","weight":-0.0667},{"period":"6month","weight":-0.3526},{"period":"1year","weight":-0.513},{"period":"ytd","weight":-0.5109}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0448},{"period":"3month","weight":0.0748},{"period":"6month","weight":0.1785},{"period":"1year","weight":0.2426},{"period":"ytd","weight":0.1602}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RenovoRx, Inc.于2012年12月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发实体瘤局部治疗的疗法，并为其主要产品候选RenovoGem进行3期注册试验。他们的治疗平台，Renovox经动脉微灌注，或Renovostamp采用经批准的化疗药物，具有有效的作用机制和良好的安全性和副作用，目的是提高其疗效，提高其安全性，并拓宽其治疗窗口。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.17996},{"month":2,"riseRate":1,"avgChangeRate":0.308925},{"month":3,"riseRate":0,"avgChangeRate":-0.199815},{"month":4,"riseRate":0,"avgChangeRate":-0.209638},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.09114},{"month":6,"riseRate":0.666667,"avgChangeRate":0.066465},{"month":7,"riseRate":0,"avgChangeRate":-0.050224},{"month":8,"riseRate":0.5,"avgChangeRate":-0.050925},{"month":9,"riseRate":0,"avgChangeRate":-0.204167},{"month":10,"riseRate":0,"avgChangeRate":-0.139635},{"month":11,"riseRate":0.666667,"avgChangeRate":0.014162},{"month":12,"riseRate":0.666667,"avgChangeRate":0.82229}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}